BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29752070)

  • 1. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
    Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.
    Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X
    World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical and Vascular Characteristics of RNF213 c.14576G>A Variant-Related Intracranial Major Artery Disease in China.
    Cheng W; Xue S; Wu F; Song X; Huang Q; Song H; Wu J
    Behav Neurol; 2019; 2019():7908392. PubMed ID: 30992731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between RNF213 c.14576G>A Variant (rs112735431) and Peripheral Pulmonary Artery Stenosis in Moyamoya Disease.
    Ozaki D; Endo H; Tashiro R; Sugimura K; Tatebe S; Yasuda S; Tomata Y; Endo T; Tominaga K; Niizuma K; Fujimura M; Tominaga T
    Cerebrovasc Dis; 2022; 51(3):282-287. PubMed ID: 34710878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of RNF213 variants in symptomatic intracranial arterial stenosis/occlusion in China.
    Sun X; Luo M; Li J; Lai R; Lin J; Wang Y; Xu X; Wu S; Sheng W
    Mol Genet Genomics; 2020 May; 295(3):635-643. PubMed ID: 32020275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Ring Finger Protein 213 Gene P.R4810k Polymorphism with Intracranial Major Artery Stenosis/Occlusion.
    Zhang Q; Yu L; Ge P; Ma Y; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1556-1564. PubMed ID: 29482934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.
    Zhang T; Guo C; Liao X; Xia J; Wang X; Deng J; Yan J
    Environ Health Prev Med; 2017 Apr; 22(1):41. PubMed ID: 29165136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of
    Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
    Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis/occlusion.
    Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Mukasa A; Nakatomi H; Shimizu T; Saito N
    Stroke; 2013 Oct; 44(10):2894-7. PubMed ID: 23970789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis/occlusion.
    Miyawaki S; Imai H; Takayanagi S; Mukasa A; Nakatomi H; Saito N
    Stroke; 2012 Dec; 43(12):3371-4. PubMed ID: 23010677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Ring Finger Protein 213 in Moyamoya Disease.
    Ma YG; Zhang Q; Yu LB; Zhao JZ
    Chin Med J (Engl); 2016 Oct; 129(20):2497-2501. PubMed ID: 27748344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
    Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
    Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
    Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis.
    Huang Y; Cheng D; Zhang J; Zhao W
    J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY
    J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.
    Ma J; Liu Y; Ma L; Huang S; Li H; You C
    Neurol India; 2013; 61(1):35-9. PubMed ID: 23466837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.